Phase 4 Study of Atorvastatin 10mg vs. 40mg in Follow-up CFR in AMI [acute myocardial infarction] Patients.
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2012
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis; Myocardial infarction
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 May 2010 Results published in Heart (British Cardiac Society).
- 14 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History